YI-CHEN LAI to Drug Resistant Epilepsy
This is a "connection" page, showing publications YI-CHEN LAI has written about Drug Resistant Epilepsy.
Connection Strength
1.346
-
New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida. Epilepsia. 2024 Apr; 65(4):1145-1146.
Score: 0.185
-
Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children. Neurology. 2023 08 01; 101(5):e546-e557.
Score: 0.176
-
Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021 11; 62(11):2766-2777.
Score: 0.155
-
Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). Epilepsia. 2021 07; 62(7):1629-1642.
Score: 0.153
-
Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open. 2021 03; 6(1):62-72.
Score: 0.149
-
First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 11 10; 95(19):e2683-e2696.
Score: 0.146
-
Electroencephalographic Reporting for Refractory Status Epilepticus. J Clin Neurophysiol. 2019 Sep; 36(5):365-370.
Score: 0.136
-
Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Epilepsy Res. 2018 08; 144:1-6.
Score: 0.123
-
Factors associated with treatment delays in pediatric refractory convulsive status epilepticus. Neurology. 2018 05 08; 90(19):e1692-e1701.
Score: 0.123